Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
The Netherlands is a country highly affected by the COVID-19 pandemic. In this study, Slot, Hogema and colleagues report a low SARS-CoV-2 seroprevalence one month into the outbreak and provide insights into virus exposure by region and age group when widespread non-pharmaceutical interventions are i...
Enregistré dans:
Auteurs principaux: | Ed Slot, Boris M. Hogema, Chantal B. E. M. Reusken, Johan H. Reimerink, Michel Molier, Jan H. M. Karregat, Johan IJlst, Věra M. J. Novotný, René A. W. van Lier, Hans L. Zaaijer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/863a9c58df364edcbc4a6ef24499c75d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
par: Dianna L. Ng, et autres
Publié: (2020) -
Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.
par: Annatina Kaufmann, et autres
Publié: (2011) -
Seroprevalence of Chikungunya (CHIK) Infection during Non Epidemic Periods in Chennai, Southern India
par: Kaliyamoorthy Kayalvili, et autres
Publié: (2021) -
Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update
par: Zsuzsa Kalmár, et autres
Publié: (2021) -
Seroprevalence of hepatitis E virus in risk populations and blood donors in a referral hospital in the south of Brazil
par: Marisa Boff Costa, et autres
Publié: (2021)